1. Home
  2. PKOH vs EVMN Comparison

PKOH vs EVMN Comparison

Compare PKOH & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Park-Ohio Holdings Corp.

PKOH

Park-Ohio Holdings Corp.

HOLD

Current Price

$38.47

Market Cap

553.5M

Sector

Industrials

ML Signal

HOLD

Logo Evommune Inc.

EVMN

Evommune Inc.

HOLD

Current Price

$11.36

Market Cap

409.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PKOH
EVMN
Founded
1907
2020
Country
United States
United States
Employees
N/A
48
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
553.5M
409.2M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
PKOH
EVMN
Price
$38.47
$11.36
Analyst Decision
Buy
Strong Buy
Analyst Count
1
10
Target Price
$37.00
$43.88
AVG Volume (30 Days)
81.1K
1.4M
Earning Date
05-06-2026
06-11-2026
Dividend Yield
1.69%
N/A
EPS Growth
N/A
N/A
EPS
0.57
N/A
Revenue
$1,599,100,000.00
N/A
Revenue This Year
$7.87
N/A
Revenue Next Year
$3.42
N/A
P/E Ratio
$66.96
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.52
$10.47
52 Week High
$39.69
$33.20

Technical Indicators

Market Signals
Indicator
PKOH
EVMN
Relative Strength Index (RSI) 61.16 32.16
Support Level $33.76 N/A
Resistance Level $39.33 $21.21
Average True Range (ATR) 1.66 0.98
MACD 0.00 0.10
Stochastic Oscillator 81.52 20.60

Price Performance

Historical Comparison
PKOH
EVMN

About PKOH Park-Ohio Holdings Corp.

Park-Ohio Holdings Corp is a diversified international company offering its clients supply chain management outsourcing services, capital equipment used on their production lines, and manufactured components used to assemble their products. The company operates through three reportable segments: Supply Technologies, Assembly Components, and Engineered Products. Maximum revenue is generated from the Supply Technologies segment, which is mainly engaged in sourcing, planning, and procurement of several production components, including fasteners, pins, nuts, bolts, valves, hoses, wire harnesses, clamps and fittings, etc. Geographically, the company generates maximum revenue from its business in the United States, followed by Europe, Asia, Mexico, Canada, and other regions.

About EVMN Evommune Inc.

Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.

Share on Social Networks: